XBP Global closes BPA deal; revenue and adjusted EBITDA rise despite net loss, high debt

Executive summary - XBP Global Holdings, Inc. (NASDAQ: CFFE)
Source: Form 10‑Q for period ended June 30, 2025 (numbers in thousands USD unless noted).

What's happening inside the company (high level)
* Completed a material post‑period acquisition: Exela Technologies BPA, LLC closed July 29, 2025 (the Company changed its name to XBP Global Holdings, Inc.). The deal issued ~81.8 million shares and expanded the business into BPA's U.S./Asia operations.
* Active integration, restructuring and related professional/legal spend tied to the acquisition and prior restructuring actions.
* Heavy related‑party activity: new service agreements (HOV Services Ltd., Nventr LLC) and related‑party payables and notes remain significant.
* Leverage and new financing activity: existing HSBC facilities in place at quarter‑end; after period close the company and the reorganized BPA sponsors implemented substantial exit financing and an ABL ($150M) under the restructuring.

Key income‑statement and balance‑sheet facts (select figures)
* Revenue - Q2 2025: $39,431 vs Q2 2024: $33,534. Six months 2025: $76,962 vs six months 2024: $71,581.
* Operating loss - Q2 2025: $(1,611); six months 2025: $(3,398).
* Net loss - Q2 2025: $(6,889) (continuing $(3,446) + discontinued $(3,443)); six months 2025: $(11,239). Basic and diluted EPS Q2 2025: $(0.19); six months: $(0.34).
* Adjusted EBITDA (continuing ops) - Q2 2025: $3,280; six months 2025: $6,974 (company uses this as core operating metric).
* Cash & equivalents - $6,121 at June 30, 2025 (down from $12,099 at 12/31/2024).
* Total assets - $105,183; Total liabilities - $133,462; Stockholders' deficit - $(28,279).
* Total debt outstanding - $32,348 (current portion $6,755; long‑term net $25,593).
* Accounts receivable, net - $33,610 (includes $8.0M unbilled receivables). Allowance for credit losses: $936 (down from $1,198).
* Pension liabilities - $11,823. Goodwill - $24,361; intangible assets (net) - $1,270.

Positive aspects of the income statement and operations
* Revenue growth: consolidated revenue up YoY (Q2 +17.9% reported; six months +7.8%).
* Improving gross margin dynamics: cost of revenue as % of revenue improved (Q2 cost of revenue 70.1% of revenue vs 80.3% prior year quarter), driven by automation and operating leverage in Bills & Payments.
* Adjusted EBITDA is positive and expanded (Q2 $3.3M), indicating core operations can be cash‑generative before acquisition, restructuring and financing items.
* Reduced allowance for credit losses and active factoring program - company improves working capital but has off‑balance factoring exposure (~$7.5M factored AR).
* Debt covenants: company reported compliance with 2024 Facilities Agreement covenants at June 30, 2025.

Negative / risk items visible in the income statement and disclosures
* Significant net loss: Q2 consolidated loss $(6.9M); six‑month loss $(11.2M). Discontinued operations materially drag reported profitability (~half of Q2 loss came from discontinued ops).
* SG&A spike: SG&A rose sharply YoY (Q2 SG&A $10.4M vs $6.0M prior), driven by bonuses, stock‑based comp, legal and acquisition related costs - pressure on near‑term profitability.
* Heavy related‑party expense: $2.4M in Q2 (services and fees), and related‑party payables of $7.6M - governance and cash‑flow dependency risk.
* Tight cash position: cash ~$6.1M at quarter‑end before closing the BPA deal (acquisition and subsequent financing materially changed capital structure).
* Balance sheet stressed: liabilities exceed assets at 6/30/25 (stockholders' deficit $(28.3M)); debt levels and pension liabilities are material relative to cash.
* Discontinued operations and litigation: printing disposal continues to produce losses; employee litigation accruals and settlements ($0.8M‑$1.0M range) remain a contingent cost.
* Foreign‑exchange volatility: FX swings caused material income volatility (Q2 foreign exchange net gain of $0.3M vs prior year loss), which can add unpredictability to reported results.

Operational & financial trends investors should watch next
* Post‑acquisition integration of BPA (impact to combined revenue, margins, and cash flow) and the accounting treatment under ASC 805.
* How the company uses and services new exit financing and the ABL facility (debt reduction vs funding working capital / integration costs).
* SG&A trajectory - whether acquisition and one‑time legal/transaction costs normalize and Adjusted EBITDA converts to free cash flow.
* Receivables and working capital: rising accounts receivable (33.6M) and use of factoring - monitor collection days and factoring costs.
* Related‑party exposure and governance (new service agreements with affiliates and chairman‑connected entities).
* Covenant compliance on new and amended facilities post‑closing (company was compliant at 6/30/25 but the balance sheet changed materially after the BPA close).

Bottom line (straightforward)
XBP reported revenue growth and positive Adjusted EBITDA from continuing operations, which shows operational improvement in its core Bills & Payments and Technology segments. But reported net losses, a small cash balance at quarter‑end, meaningful debt and pension liabilities, elevated SG&A (acquisition and restructuring costs), and substantial related‑party activity create near‑term execution and financing risk. The July 29, 2025 BPA acquisition is transformational in scale - it materially changes capitalization and funding (new share issuances, exit financing and an ABL). Investors should focus on integration execution, cash generation post‑close, debt servicing under new facilities, and whether core margins and working capital trends sustain the improving Adjusted EBITDA trajectory.

If you want, I can produce a one‑page quick ratio/debt schedule, a simple cash‑flow sensitivity (post‑BPA), or a short checklist of catalysts and red flags to monitor over the next 90 days.